Pharma BD Deal Intelligence

Novo Holdings A/S / Catalent, Inc.

2016 · Acquisition/Merger · $16.5B · Complete

Announcement Sentiment

88

Strongly positive

Outcome Score

68

Largely worked — most objectives met.

Novo Holdings acquired Catalent for $16.5B for CDMO manufacturing.

Key facts

Announced Jan 22, 2016
Closed Dec 18, 2024
Deal value $16.5B
Deal type Acquisition/Merger
Indications Biologics CDMO Services, Pharma & Consumer Health CDMO
Key assets Non-pharma deal

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals